Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

LUYE PHARMA GROUP LTD.

綠 叶 制 药 集 团 有 限 公 司

(Incorporated in the Bermuda with limited liability)

(Stock Code: 02186)

NOTICE OF BOARD MEETING

The board of directors (the ''Board'') of Luye Pharma Group Ltd. (the ''Company'') hereby announces that a meeting of the Board will be held on Wednesday, 29 March 2017, for the purpose of, among other matters, approving the annual results of the Company and its subsidiaries for the year ended 31 December 2016 and the publication and considering the payment of a final dividend, if any.

By order of the Board

LUYE PHARMA GROUP LTD.

Liu Dian Bo

Chairman

Hong Kong, 15 March 2017

As at the date of this announcement, the executive directors of the Company are Mr. LIU Dian Bo, Mr. YANG Rong Bing, Mr. YUAN Hui Xian and Ms. ZHU Yuan Yuan; and the independent non-executive directors are Mr. ZHANG Hua Qiao, Professor LO Yuk Lam, Mr. LEUNG Man Kit and Mr. CHOY Sze Chung Jojo.

Luye Pharma Group Ltd. published this content on 15 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 29 March 2017 10:59:14 UTC.

Original documenthttp://www.luye.cn//lvye_en/uploads//2017-03/29/_1490784948_4lqzeg.pdf

Public permalinkhttp://www.publicnow.com/view/046B51615A76B0E0F2AEB878E32040E6A0BBE1D6